News
A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...
“Semaglutide has been in the US for more than eight years now. In India also, the oral version of this molecule is there for ...
10h
Money Talks News on MSNWegovy Fallout: How Novo’s Exit Hits Your Wallet and Waistline
Novo Nordisk announced it is cutting ties with telehealth giant Hims & Hers Health, pulling its blockbuster drug Wegovy from ...
The products reported missing include insulin formulations marketed as Ryzodeg FlexTouch and Fiasp (Penfill and FlexTouch), ...
21h
India Today on MSNNovo Nordisk insulin and weight loss injections stolen in transit, alert issued
The regulator in its health alert letter mentioned that these stolen drugs are rDNA injectables that require strict ...
BDCDA alerts traders in Karnataka on Novo Nordisk insulins & semiglutide injections’ pilferage in transit: Nandita ...
Novo Nordisk's economic moat is eroding due to increased competition and US drug price pressures, but growth in international ...
BRITAIN has gone fat jab crazy — with sales of Wegovy soaring by more than 2,000 per cent in the past month. Dieters are ...
19h
India Today on MSNCDSCO flags stolen insulin, Wegovy: What patients must check before purchase
Certain batches of injectable medicines, including insulin and weight-loss drugs, were reported stolen in transit. Experts ...
Novo Nordisk, the maker of the blockbuster diabetes drug Ozempic, is at the center of a brewing legal storm. Once celebrated ...
16h
Zacks Investment Research on MSNIs Orforglipron Pill Setback End of the Road for LLY's Obesity Plans?
Eli Lilly and Company LLY is a key player in the diabetes and obesity drug market, mainly due to the significant popularity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results